Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Vietnam

Ampharco Receives Investment

February 2008 | Company News Alert

The goal of Vietnam Pharmaceutical Joint Stock Company (Ampharco) to export its products to the US and other foreign markets has received a boost after investment funds were received from Vietnam Equity Holding (VEH). The new resources will be used to restructure Ampharco's finances and 'improve competitive capacity'. BMI expects Vietnam's pharmaceutical exports to reach US$760mn by 2012. However, if more deals like the Ampharco/VEH partnership are signed, we will revise this forecast

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>